Autoantibodies against MSH2, GNAS, and survivin presented the highest diagnostic performance for HCC, with AUCs of 0.766, 0.747, and 0.750, and sensitivities of 42.1%, 48.4%, and 42.4%, respectively (all p < 0.001). The gene discussed is MSH2; the disease is hepatocellular carcinoma.